Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

Medical - Diagnostics & Research

Healthcare
$1.59 +2.44%

+$0.13 today

Market cap
$52.08M
Beta
1.79
P/E (TTM)
-3.9
EPS (TTM)
-$1.39
52W Low $2.33High $8.51

Volume 0.64M

Average 0.38M

Income Statement

Follow revenue through to earnings.

Revenue

$4.05M

FY 2025 · Annual

+115.6% YoY

Operating Income

-$30.58M

FY 2025 · Annual

Net Income

-$50.22M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.2M958K1.5M1.88M4.06M
Cost of Revenue778K976K1.09M1.14M3.87M
Gross Profit1.42M(18K)413K740K190K
Gross Margin64.6%-1.9%27.5%39.3%4.7%
Research & Development5.04M7.3M9.29M9.84M15.9M
Selling, General & Admin20.39M21.53M13.29M13.79M16.98M
Operating Expenses55.15M17.98M25.55M61.78M30.77M
Depreciation & Amortization4.21M5.22M1.68M1.56M2.2M
EBITDA(48.46M)(13.31M)(23.12M)(59.02M)(47.92M)
EBITDA Margin-2204.6%-1389.2%-1538.5%-3137.4%-1181.7%
Operating Income(53.73M)(18M)(25.14M)(61.04M)(30.58M)
Operating Margin-2444.3%-1878.6%-1672.4%-3245.1%-754.1%
Interest Income00000
Interest Expense209K83K52K84K109K
Other Income / Expenses854K(615K)281K378K(19.64M)
Income Before Tax(52.87M)(18.61M)(24.86M)(60.66M)(50.22M)
Pre-Tax Margin-2405.4%-1942.8%-1653.7%-3225.0%-1238.5%
Income Tax Expense(9.26M)0000
Net Income(64.1M)(72.9M)(27.78M)(60.66M)(50.22M)
Net Margin-2916.2%-7609.8%-1848.4%-3225.0%-1238.5%
EPS (Basic)(14.40)(20.00)(3.75)(4.66)(1.65)
EPS (Diluted)(14.40)(20.00)(3.75)(4.66)(1.65)
Weighted Avg Shares4.45M5.54M7.65M13.07M30.48M
Weighted Avg Shares (Diluted)4.45M5.54M7.65M13.07M30.48M

IMDX Earnings Waterfall · TTM

NASDAQ:IMDX · Revenue to Net Income

Key Ratios

EPS$-1.51
Gross Margin-431.9%
Net Margin-5369.2%
P/E Ratio-3.5
P/S Ratio1083.7

Analysis

$1.9M of revenue converted into -$47.8M of net income for the selected period. Gross margin is -431.9% and net margin is -5369.2%, showing how much revenue survives after costs and taxes. EPS is $-1.51, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 21, 2026
10-QQuarterly reportAug 10, 2026
8-KCurrent reportAug 10, 2026
S-8S-8 filingJul 24, 2026
4Statement of changes in beneficial ownershipJul 6, 2026

How much revenue does IMDX generate?

Insight Molecular Diagnostics Inc. (IMDX) reported $4.05M of revenue in fiscal 2025.

Is IMDX profitable?

Insight Molecular Diagnostics Inc. (IMDX) reported -$50.22M of net income, with a net margin of -1238.5%.